A novel biomarker of interleukin 6 activity and clinical and cognitive outcomes in depression
Éimear M. Foley(University of Bristol), Golam M. Khandaker(University of Bristol), Muzaffer Kaşer(Cambridgeshire and Peterborough NHS Foundation Trust), Louise Ziegler(Karolinska Institutet), Chloe Slaney(University of Bristol), Nicholas A Donnelly(At Bristol)
Cited by 32
Related Papers
Prevalence of low-grade inflammation in depression: a systematic review and meta-analysis of CRP levels
|Psychological Medicine|2019|735
Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions
|Molecular Psychiatry|2016|648
National Institute of Neurological Disorders and Stroke Consensus Diagnostic Criteria for Traumatic Encephalopathy Syndrome
|Neurology|2021|322
Peripheral blood cellular immunophenotype in depression: a systematic review and meta-analysis
|Molecular Psychiatry|2022|122